Patent · US Active

Agents that activate CD47 and their use in the treatment of inflammation

US11142548B2 · kind B2 · utility

0Cited by

10References

5Claims

0Family size

Assignees

Sorbonne Universite · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR

Inventors

Florian Sennlaub · Paris, FR
Michael Housset · Keyano, CA
Xavier Guillonneau · Boulogne-Billancourt, FR
Jose-Alain Sahel · Paris, FR
Philippe Karoyan · Paris, FR

Key dates

Filing date	May 10, 2017
Grant date	Oct 12, 2021
Priority date	—
Expiry date	Oct 15, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are agents activating CD47 and their use in the treatment of inflammation, in particular non-resolving low grade inflammation, characterized by chronic MP infiltration, such as age-related macular degeneration. Also disclosed are pharmaceutical compositions, medicaments and kits including the agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.